Idioma:

THE IMPACT OF DRUG–ELUTING STENT TYPE ON LATE RESTENOSIS AND LATE REGRESSION

Hyodo, Yusuke ; Kadota, Kazushige ; Fuku, Yasushi ; Miyake, Koshi ; Hayakawa, Yuki ; Saito, Naoki ; Otsuji, Hideaki ; Otsuru, Suguru ; Hasegawa, Daiji ; Shigemoto, Yoshikazu ; Habara, Seiji ; Tanaka, Hiroyuki ; Tada, Takeshi ; Goto, Tsuyoshi ; Mitsudo, Kazuaki

Journal of the American College of Cardiology, 2013-03, Vol.61 (10), p.E1662-E1662 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Título:
THE IMPACT OF DRUG–ELUTING STENT TYPE ON LATE RESTENOSIS AND LATE REGRESSION
Autor: Hyodo, Yusuke ; Kadota, Kazushige ; Fuku, Yasushi ; Miyake, Koshi ; Hayakawa, Yuki ; Saito, Naoki ; Otsuji, Hideaki ; Otsuru, Suguru ; Hasegawa, Daiji ; Shigemoto, Yoshikazu ; Habara, Seiji ; Tanaka, Hiroyuki ; Tada, Takeshi ; Goto, Tsuyoshi ; Mitsudo, Kazuaki
Assuntos: Angioplasty ; Cardiology ; Cardiovascular ; Internal Medicine ; Stents
É parte de: Journal of the American College of Cardiology, 2013-03, Vol.61 (10), p.E1662-E1662
Descrição: Methods From November 2002 to December 2011, 12069 consecutive patients (17272 lesions) were treated with sirolimus-eluting stent (SES: 6336 lesions), paclitaxel-eluting stent (PES: 1536 lesions), zotarolimus-eluting stent (ZES: 635 lesions), everolimus-eluting stent (EES: 2869 lesions), and BMS (5896 lesions), and underwent midterm follow-up coronary angiography (f/u CAG) at 8 months after implantation and late f/u CAG at 12 month after midterm f/u.
Editor: New York: Elsevier Inc
Idioma: Inglês

Voltar para lista de resultados